These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 205786)

  • 81. Erythrocyte transketolase activity in uremia.
    Kuriyama M; Mizuma A; Yokomine R; Igata A; Otuji Y
    Clin Chim Acta; 1980 Dec; 108(2):169-77. PubMed ID: 6256098
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Does hypermagnesemia suppress parathyroid activity and therefore play a role in amelioration of uremic toxicity?
    Oe PL; van der Meulen J; Lips PT; de Vries PM; van Bronswijk H; Donker AJ
    Adv Exp Med Biol; 1987; 223():149-52. PubMed ID: 3447431
    [No Abstract]   [Full Text] [Related]  

  • 83. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR).
    Zakrzewska-Pniewska B; Jedras M
    Neurophysiol Clin; 2001 Jun; 31(3):181-93. PubMed ID: 11488229
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Uremic toxin and dialysis].
    Nakagawa S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):430-2. PubMed ID: 988349
    [No Abstract]   [Full Text] [Related]  

  • 85. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients.
    Goldstein DA; Feinstein EI; Chui LA; Pattabhiraman R; Massry SG
    J Clin Endocrinol Metab; 1980 Jul; 51(1):130-4. PubMed ID: 6892917
    [No Abstract]   [Full Text] [Related]  

  • 86. [Uremic polyneuropathy: clinico-electroneurographic study of 36 cases].
    Werneck LC; Mulinari AS; Laffite A; Kesikowski LB
    Arq Neuropsiquiatr; 1979 Dec; 37(4):356-72. PubMed ID: 93959
    [No Abstract]   [Full Text] [Related]  

  • 87. Detection of uremic neuropathy by reflex response latency.
    Knoll O; Dierker E
    J Neurol Sci; 1980 Aug; 47(2):305-12. PubMed ID: 6251176
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Famotidine reduces serum parathyroid hormone levels in uremic patients.
    Arik N; Arinsoy T; Sayín M; Taşdemir I; Yasavul U; Turgan C; Caglar S
    Nephron; 1991; 59(2):333. PubMed ID: 1956503
    [No Abstract]   [Full Text] [Related]  

  • 89. Normal and pathologic concentrations of uremic toxins.
    Duranton F; Cohen G; De Smet R; Rodriguez M; Jankowski J; Vanholder R; Argiles A;
    J Am Soc Nephrol; 2012 Jul; 23(7):1258-70. PubMed ID: 22626821
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessment of the characteristics and quality of life of patients with uremic peripheral neuropathy
.
    Yu XZ; Lu S; Gou W; Wang W; Zou SH; Han YX; Wang WW; Zhang JY
    Clin Nephrol; 2017 Mar; 87 (2017)(3):134-139. PubMed ID: 28102815
    [TBL] [Abstract][Full Text] [Related]  

  • 91. H reflexes as a measure for uremic polyneuropathy. A longitudinal study in patients treated with dialysis or renal transplantation.
    De Weerd AW; Nihom J; Rozeman CA; Poortvliet DC; Jonkman EJ; Van der Maas AP; Tjandra YI
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):276-80. PubMed ID: 7521287
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Uremic neuropathy: evidence of middle molecule toxicity.
    Milutinovic J; Babb AL; Eschbach JW; Follette WC; Graefe U; Strand MJ; Scribner BH
    Artif Organs; 1978 Feb; 2(1):45-51. PubMed ID: 687020
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Peripheral motor nerve conduction velocities in children undergoing chronic hemodialysis.
    Mentser MI; Clay S; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Fine RN
    Nephron; 1978; 22(4-6):337-41. PubMed ID: 216941
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Is parathyroid hormone a uremic toxin?
    Massry SG
    Nephron; 1977; 19(3):125-30. PubMed ID: 895963
    [No Abstract]   [Full Text] [Related]  

  • 96. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients.
    Kuwabara S; Nakazawa R; Azuma N; Suzuki M; Miyajima K; Fukutake T; Hattori T
    Intern Med; 1999 Jun; 38(6):472-5. PubMed ID: 10411351
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Neuropathy and "middle" molecule toxins.
    Funck-Brentano JL; Man NK; Sausse A; Cueille G; Zinfraff J; Drueke T; Jungers P; Billon JP
    Kidney Int Suppl; 1975 Feb; (3):352-6. PubMed ID: 1057710
    [No Abstract]   [Full Text] [Related]  

  • 98. Role of parathyroid hormone in the pathogenesis of the uremic manifestations.
    Massry SG
    Klin Wochenschr; 1979 Oct; 57(19):1085-8. PubMed ID: 392183
    [TBL] [Abstract][Full Text] [Related]  

  • 99. On the pathogenesis of the uremic state--an exposition of the trade-off hypothesis.
    Bricker NS
    Nihon Jinzo Gakkai Shi; 1974 Apr; 16(4):327-39. PubMed ID: 4474520
    [No Abstract]   [Full Text] [Related]  

  • 100. Electrophysiological course of uraemic neuropathy in haemodialysis patients.
    Ogura T; Makinodan A; Kubo T; Hayashida T; Hirasawa Y
    Postgrad Med J; 2001 Jul; 77(909):451-4. PubMed ID: 11423596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.